$185 Million is the total value of Eversept Partners, LP's 54 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MYL | New | MYLAN N Vcall | $4,345,640 | – | 158,600 | +100.0% | 2.35% | – |
| TSRO | New | TESARO INC | $2,673,000 | – | 36,000 | +100.0% | 1.45% | – |
| FATE | New | FATE THERAPEUTICS INC | $2,116,950 | – | 165,000 | +100.0% | 1.15% | – |
| QGEN | New | QIAGEN NV | $1,905,085 | – | 55,300 | +100.0% | 1.03% | – |
| ILMN | New | ILLUMINA INC | $1,544,040 | – | 5,148 | +100.0% | 0.84% | – |
| GHDX | New | GENOMIC HEALTH INC | $1,537,209 | – | 23,866 | +100.0% | 0.83% | – |
| MYL | New | MYLAN N V | $1,507,000 | – | 55,000 | +100.0% | 0.82% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,463,003 | – | 69,700 | +100.0% | 0.79% | – |
| LOXO | New | LOXO ONCOLOGY INC | $1,400,700 | – | 10,000 | +100.0% | 0.76% | – |
| NTRA | New | NATERA INC | $551,964 | – | 39,539 | +100.0% | 0.30% | – |
| FLDM | New | FLUIDIGM CORP DEL | $434,922 | – | 50,455 | +100.0% | 0.24% | – |
| OPNT | New | OPIANT PHARMACEUTICALS INC | $200,869 | – | 13,901 | +100.0% | 0.11% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $159,229 | – | 73,717 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.